RE:RE:RE:RE:Any analyst downgradesI dont think so. Paul clearly said that "We plan to keep the market well informed of our activities and intend to announce trial recruitment updates throughout the remainder of the year. At the pace we're going, we believe that by the end of the first half of fiscal '24, we will be able to announce preliminary safety and efficacy data."
I believe they would update the progress of recruitment by the end of yar and update the preliminary efficacy in 1H2024.